<p>THP-1 monocytes were preincubated with the PI3K inhibitor LY294002 (LY) or wortmannin (WM) for 1 h, and then were infected with <i>T</i>. <i>gondii</i> at MOI 10 for 30 min. The cellular lysates were separated by SDS-PAGE and analyzed by immunoblotting using phospho-specific primary antibodies against AKT (Ser473), p38 MAPK, ERK1/2, and JNK. To ensure equal protein loading, the blots were stripped and reprobed with antibodies against AKT, p38 MAPK, ERK1/2, and JNK. A representative experiment of three independent replicates with similar results is shown.</p
<p>(A) HeLa cells were treated with control or IPMK siRNA for 48 h. Cells were infected with wild ty...
<p><b>A:</b> Cells from the T1, T10C and control cells (wt T11hT) were cultured in DMEM+10%FBS for 2...
<p>THP-1 cells were preincubated with anti-TLR2, anti-TLR4 or isotype-matched control (IC) (10 μg/mL...
<p>(A)THP-1 cells were infected with <i>T</i>. <i>gondii</i> at MOI 10 for the indicated time and th...
<p>The p38 inhibitor (SB203580), ERK inhibitor (PD98059), or JNK inhibitor (SP600125) was added to T...
<p><i>A</i>, Primary HBMEC were challenged with type I (RH) or type II (ME49) strains of <i>T. gondi...
<p>PI3K inhibitor LY294002 (LY) or wortmannin (WM) was added to THP-1 cells at the concentrations in...
<p>(A) HeLa cells were treated with different concentrations of LY294002 (1 µM to 100 µM) for 30 min...
<p><i>A</i>, HBMEC, mHEVc and human RPE cells were incubated with or without Akt inhibitor IV (1.25 ...
<p>The PI3K/AKT and MAPK pathways are activated by <i>T</i>. <i>gondii</i>-infection via TLR2 and TL...
<div><p>(A) Representative immunoblot showing ERK-p, P38-p, and JNK-p, in uninfected cells before (0...
<p><i>A</i>, mHEVc cells were transfected with control siRNA or EGFR siRNA. Expression of EGFR and a...
<p><i>A</i>, <i>B, C</i> HBMEC were challenged with ΔH<sub>x</sub> (WT), MIC1 ko, MIC3 ko, MIC1-3 ko...
<div><p>Interleukin (IL)-23 and IL-12 are closely related in structure, and these cytokines regulate...
<p><i>A</i>, HBMEC were treated with or without pertussis toxin (PTx; 100 ng/mL) for 4 h prior to ch...
<p>(A) HeLa cells were treated with control or IPMK siRNA for 48 h. Cells were infected with wild ty...
<p><b>A:</b> Cells from the T1, T10C and control cells (wt T11hT) were cultured in DMEM+10%FBS for 2...
<p>THP-1 cells were preincubated with anti-TLR2, anti-TLR4 or isotype-matched control (IC) (10 μg/mL...
<p>(A)THP-1 cells were infected with <i>T</i>. <i>gondii</i> at MOI 10 for the indicated time and th...
<p>The p38 inhibitor (SB203580), ERK inhibitor (PD98059), or JNK inhibitor (SP600125) was added to T...
<p><i>A</i>, Primary HBMEC were challenged with type I (RH) or type II (ME49) strains of <i>T. gondi...
<p>PI3K inhibitor LY294002 (LY) or wortmannin (WM) was added to THP-1 cells at the concentrations in...
<p>(A) HeLa cells were treated with different concentrations of LY294002 (1 µM to 100 µM) for 30 min...
<p><i>A</i>, HBMEC, mHEVc and human RPE cells were incubated with or without Akt inhibitor IV (1.25 ...
<p>The PI3K/AKT and MAPK pathways are activated by <i>T</i>. <i>gondii</i>-infection via TLR2 and TL...
<div><p>(A) Representative immunoblot showing ERK-p, P38-p, and JNK-p, in uninfected cells before (0...
<p><i>A</i>, mHEVc cells were transfected with control siRNA or EGFR siRNA. Expression of EGFR and a...
<p><i>A</i>, <i>B, C</i> HBMEC were challenged with ΔH<sub>x</sub> (WT), MIC1 ko, MIC3 ko, MIC1-3 ko...
<div><p>Interleukin (IL)-23 and IL-12 are closely related in structure, and these cytokines regulate...
<p><i>A</i>, HBMEC were treated with or without pertussis toxin (PTx; 100 ng/mL) for 4 h prior to ch...
<p>(A) HeLa cells were treated with control or IPMK siRNA for 48 h. Cells were infected with wild ty...
<p><b>A:</b> Cells from the T1, T10C and control cells (wt T11hT) were cultured in DMEM+10%FBS for 2...
<p>THP-1 cells were preincubated with anti-TLR2, anti-TLR4 or isotype-matched control (IC) (10 μg/mL...